Natalya (Desogestrel, Ethinylestradiol)

Desogestrel is converted in the body to an active progestin that inhibits the luteinising hormone surge, preventing ovulation. Ethinylestradiol, a synthetic estrogen, stabilises the endometrial lining and thickens cervical mucus, creating a hostile environment for sperm and reducing the chance of implantation.

The dosing regimen for Natalya is determined by the prescribing healthcare professional. Typically, the medication is taken as one tablet daily at the same time each day, but the exact schedule and duration are individualized based on the patient’s clinical needs.

Natalya is contraindicated during pregnancy because it is intended to prevent conception, not to treat an existing pregnancy. While limited data exist for breastfeeding, combined oral contraceptives are generally considered compatible with lactation, though clinicians may weigh benefits against potential effects on milk production.

To order Natalya, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Natalya contains desogestrel, a third‑generation progestin, which is associated with a lower incidence of androgenic side effects compared with older agents such as levonorgestrel. Its efficacy in preventing pregnancy is comparable to other combined pills, while the side‑effect profile may differ slightly, offering an alternative for patients seeking reduced acne or weight‑related concerns.

Natalya tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack, protect from moisture and direct light, and store out of reach of children. Do not use tablets that appear discoloured or damaged.

Natalya is taken orally as a tablet. The recommended practice is to swallow one tablet each day, preferably at the same time, with or without food. Consistent daily intake maintains hormone levels and maximises contraceptive effectiveness.

The most serious adverse events linked to combined oral contraceptives like Natalya include venous thromboembolism (deep‑vein thrombosis or pulmonary embolism), arterial thrombosis (stroke or myocardial infarction), and severe allergic reactions. Patients should seek immediate medical attention if they experience sudden chest pain, shortness of breath, severe headache, or signs of an allergic reaction.

Natalya is contraindicated in women who are pregnant, have a history of thromboembolic disorders, uncontrolled hypertension, severe liver disease, or known hypersensitivity to its components. It should also be avoided by smokers over 35 years of age and by individuals with certain hormone‑dependent cancers.